Then, if you havent lost at least 5% on the highest dose, you actually have to stop taking it
Dynamic pet/ct imaging of 18 F-(2s, 4r)4-fluoroglutamine in healthy volunteers and oncological patients
Twenty patients had hepatic resection for metastasized colorectal carcinoma (mCRC), 10 for hepatocellular carcinoma (HCC), 12 for intrahepatic or perihilar cholangiocarcinoma carcinoma (iCCA/pCCA), 1 for neuroendocrine liver metastasis (NELM), 1 for non-neuroendocrine non-colorectal (NNECR) liver metastasis and 2 patients had benign liver lesions
Whether your goal is appetite regulation, blood sugar balance, reduced cravings, or simply seeing how your body responds to GIP/GLP-1 activation before committing to higher doses, every plan begins with a thorough medical evaluation tailored to your unique physiology
[1] [2] Using improperly stored GLP-1 medication may result in inadequate glycemic control for patients with type 2 diabetes, potentially leading to hyperglycemia